EMR — Emerson Electric Co.

The most recent Q3 FY26 report beat expectations — revenue of $4.87B versus roughly $4.80B consensus, with adjusted EPS of $1.71 versus $1.68 — and the market is leaning into the AI/data-center power buildout narrative. Sell-side reactions were positive in August 2026, including Evercore ISI raising its target to $190 and Citigroup to $182, while the stock has held up just below its 52-week high with a neutral RSI. The bullish sentiment is real, but it is partially offset by the stock's rich trailing valuation.

Revenue growth is clearly accelerating: YoY growth was roughly 1.4% in the Dec-2024 quarter, moved into the 4–5% range through FY25, and reached 7.0% in Q3 FY26 ($4.873B vs. $4.553B a year earlier). Gross margin expanded to 54.5% in Q3 FY26 from 52.6% in Q3 FY25, and operating margin improved to about 20.5%. GAAP diluted EPS rose 23% YoY to $1.28. The Dec-2023 quarter's depressed operating income ($365M) looks like a one-off distortion rather than a structural trend; excluding that blip, the trajectory has been steadily higher. This is not just a one-quarter wiggle — the Q3 FY26 sequential and YoY strength, plus the $11B+ project pipeline, suggest the acceleration has momentum.

As of 2026-08-27, the trailing valuation is expensive: P/E is 34.4x and P/S is 4.74x versus 5-year averages of 26.0x and 3.77x. The forward P/E is much more moderate at roughly 24.1x based on next-FY consensus EPS of $6.555, but that assumes a large earnings step-up. The market is paying up for expected FY27 growth, not for historical earnings. Relative to its own history, Emerson is rich on trailing metrics and about fairly valued on forward metrics if the consensus estimates prove achievable.

The stock is pricing in a substantial FY27 earnings jump from roughly $4.61 TTM EPS to $6.56 consensus. At $157.72, you are paying about 34x trailing earnings but 24x next-year earnings — a bet that process automation, AI power demand, and software growth deliver on plan. The Q3 beat and robust backlog tilt in favor of estimates being achievable, but the Nov-10 FY27 guide is the make-or-break event. If guidance misses, the multiple can compress quickly; if guidance is raised, the stock likely grinds toward the $168–$186 analyst target zone.

As of 2026-08-27, RSI was 54.8 — neutral, not overbought or oversold. Price was 0.6% below the 20-day SMA, 5.9% above the 50-day SMA, and 11.0% above the 200-day SMA, so the medium- and long-term trends are still up while short-term momentum is just pausing. The stock is only about 5% below its 52-week high of $166.35, so chasing here is less attractive than waiting for a dip toward the 20-day or 50-day support zone around $149–$153.

• AI data-center power demand is driving orders for Emerson's Ovation power-plant controls and grid-reliability hardware.
• LNG and energy-infrastructure capex remains a strong tailwind for Emerson's core process automation franchise.
• Interest rates are the swing factor: high financing costs can delay long-cycle industrial projects, though Emerson's multi-billion-dollar backlog cushions near-term revenue.
• Global manufacturing/PMI and discrete automation demand are softer than process automation, creating a mixed end-market picture.
• The ongoing shift toward software/subscription revenue changes Emerson's margin profile and valuation support over time.

• Q4 and full-year FY26 earnings scheduled for November 10, 2026 — Wall Street will be focused on FY27 EPS guidance, margin assumptions, and the software revenue target of $3.5B.
• Continued AI-driven power-generation and LNG contract wins, plus conversion of the $11B+ project pipeline into revenue.
• Capital-return execution: the $0.56 quarterly dividend and multi-year buyback authorization support the stock's downside.
• August 2026 management changes around software/AI scaling could either accelerate the transformation or create short-term execution noise.

• Valuation multiple compression: at 34.4x trailing earnings, any guidance disappointment would hit the stock hard.
• A cyclical downturn in discrete automation or broader industrial capex could derail the FY27 EPS estimate of $6.555.
• Balance-sheet friction: current ratio is 0.90 and debt-to-equity is 0.68, leaving less liquidity cushion if free cash flow dips.
• Software/AI transformation and management reshuffling create execution risk, and one major sell-side firm (Morgan Stanley) still has a Sell rating and a $135 target.

Emerson is a high-quality automation franchise with genuine momentum — accelerating revenue, expanding margins, strong free cash flow, and exposure to durable AI-power and LNG tailwinds. But as of 2026-08-27, the stock is priced for a large FY27 earnings step-up rather than offering a margin of safety. Risk/reward is balanced: it is a reasonable long-term holding, but not a low-risk entry at this price — the more attractive setup would be a pullback or a confirmed raise in FY27 guidance on November 10.

Used a forward P/E approach: applied a 25.0x multiple to consensus next-FY EPS of $6.555, roughly one turn below Emerson's 5-year average P/E of 26.0 to reflect cyclicality and the sub-1.0 current ratio. That yields a fair value of $163.88, implying the stock is approximately fully valued with modest upside from the 2026-08-27 price of $157.72.